“Laboratory Assessment of Liver Function in People Starting Antiretroviral Therapy With Dolutegravir or Efavirenz: A Cohort Study in Belo Horizonte, Brazil”. Research, Society and Development, vol. 11, no. 13, Sept. 2022, p. e74111335082, https://doi.org/10.33448/rsd-v11i13.35082.